Prior Authorization For Specialty Medications: What To Do After A Denial
For patients diagnosed with cancer, rheumatoid arthritis, Crohn’s disease, or other complex conditions, obtaining specialty medications can feel like running an obstacle course. The single biggest hurdle in this process is prior authorization (PA)—a requirement by health plans that your doctor obtain approval before a drug is dispensed or administered.
Prior authorization can be especially stressful for cancer treatment, rheumatoid arthritis, Crohn's disease, multiple sclerosis, rare disease medication, and other specialty-drug situations because delays can feel medically and financially frightening. A denial does not always mean the drug is excluded; sometimes the plan says records, step therapy history, lab values, diagnosis codes, or pharmacy-benefit criteria are missing.
Common Reasons for Specialty Medication Denials
Understanding why your medication was denied is the first step to overturning the decision. Most denials fall into one of four categories:
Insufficient Clinical Documentation: The insurer requires specific clinical markers (such as HER2, EGFR, or PD-L1 biomarker results in cancer patients), staging data, or complete treatment history.
Step Therapy Requirements: The insurer requires you to try and fail on a cheaper, preferred medication first.
Administrative or Clerical Errors: Typographical errors, incorrect billing codes (CPT/HCPCS codes), or missing National Provider Identifier (NPI) numbers.
Medical Necessity Disputes: The insurance company's medical reviewer disagrees with your doctor's clinical assessment.
Prior Authorization Reform in 2026
CMS has finalized prior authorization and interoperability rules that affect certain payers, including Medicare Advantage, Medicaid, CHIP, and Qualified Health Plan issuers on federally facilitated exchanges. The timing and details can vary by payer type and requirement, so check the denial notice and plan materials. In general, the rule is meant to improve:
Decision Timelines: Certain regulated payers have shorter decision timeframes for prior authorization requests, including urgent and standard requests. Check the rule, plan type, and notice for the exact deadline that applies.
Specific Rationales: Payers covered by the rule must give more specific reasons when denying prior authorization requests.
Electronic PA (ePA): The rule phases in electronic prior authorization and data-exchange requirements.
Transparency: Covered payers have public reporting obligations for prior authorization metrics.
The Peer-to-Peer Review: Your Fastest Tactic
If your prior authorization is denied due to a "medical necessity" dispute, one possible way to clarify it is to ask your physician to request a Peer-to-Peer Review.
In a peer-to-peer review, your doctor speaks directly with the insurance company's medical director or reviewer to explain the clinical reasoning behind the prescription. In many cases, the insurer’s initial reviewer is not a specialist in your condition (for example, a family medicine doctor reviewing a complex oncology regimen). Once your specialist explains the clinical context, the plan may have enough context to reconsider or explain what is still missing.
What to Ask Your Doctor
Ask your healthcare provider:
"Can we schedule a peer-to-peer review with the insurer's medical director? If they refuse or uphold the denial, can we cite the National Comprehensive Cancer Network (NCCN) or other specialist guidelines in our formal appeal?"
How To Build A Stronger Appeal Packet
If a peer-to-peer review does not resolve the issue, you must file a formal appeal. Your appeal package should include:
A Detailed Letter of Medical Necessity: Written by your doctor, explaining your diagnosis, staging, why alternative treatments are inappropriate, and the clinical risks of delaying this specific therapy.
Clinical Evidence: Copies of lab results, imaging, biopsy reports, and biomarker testing.
Medical Literature: Peer-reviewed studies or clinical guidelines (e.g., NCCN guidelines) supporting the use of the drug for your specific condition.
Appeal Log: Document every phone call, name, date, and conversation outline with the insurer.
For complex cases, organizations like the Patient Advocate Foundation (patientadvocate.org) and Triage Cancer (triagecancer.org) provide free case management to help you navigate the appeal process.
How Caira by Unwildered can help
If you are staring at a denial letter, EOB, policy PDF, bill, or medical record and do not know what to ask next, Caira by Unwildered is AI help for healthcare paperwork. Upload the documents, ask questions, draft next-step messages, and turn the problem into a calmer checklist 24/7. Plans are $21/month, and you can start chatting in 30 seconds at https://caira.unwildered.co.uk.
Useful starting points
This article is general information, not medical, legal, insurance, or financial advice.
